US9272994B1ActiveUtility

Ginger metabolites and uses thereof

77
Assignee: NORTH CAROLINA A&T STATE UNIVERSITYPriority: Dec 19, 2012Filed: Dec 19, 2013Granted: Mar 1, 2016
Est. expiryDec 19, 2032(~6.4 yrs left)· nominal 20-yr term from priority
C07C 323/58A23L 1/3002A23L 33/10
77
PatentIndex Score
4
Cited by
68
References
13
Claims

Abstract

The present application generally relates to the use of metabolites of ginger and analogs thereof for the treatment and prevention of diseases, including but not limited to, cancer.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
       1. A compound having the formula: 
       
         
           
           
               
               
           
         
         wherein n is selected from the group of 2, 4, 6 and combinations thereof; and 
         the compound is in an isolated or purified form. 
       
     
     
       2. The compound of  claim 1  as a pharmaceutically acceptable salt. 
     
     
       3. The compound of  claim 1  as a pharmaceutically acceptable hydrate. 
     
     
       4. A pharmaceutical composition comprising a unit dose of an active ingredient and a pharmaceutical grade carrier wherein said active ingredient is a compound having the formula: 
       
         
           
           
               
               
           
         
         and wherein n is selected from the group consisting of 2, 4, 6 and combinations thereof. 
       
     
     
       5. The pharmaceutical composition of  claim 4 , wherein said active ingredient is a pharmaceutically acceptable salt or hydrate of said formula. 
     
     
       6. The pharmaceutical composition of  claim 4 , wherein said compound is in an isolated or purified form. 
     
     
       7. A nutraceutical composition comprising an active ingredient and a food grade carrier wherein said active ingredient is a compound having the formula: 
       
         
           
           
               
               
           
         
         and wherein n is selected from the group consisting of 2, 4, 6 and combinations thereof. 
       
     
     
       8. The nutraceutical composition of  claim 7 , wherein said active ingredient is a pharmaceutically acceptable salt or hydrate of said formula. 
     
     
       9. The nutraceutical composition of  claim 7 , wherein said compound is in an isolated or purified form. 
     
     
       10. The nutraceutical composition of  claim 7  wherein n consists essentially of 2 and 4. 
     
     
       11. The nutraceutical composition of  claim 7  wherein n consists essentially of 2 and 6. 
     
     
       12. The nutraceutical composition of  claim 7  wherein n consists essentially of 4 and 6. 
     
     
       13. The nutraceutical composition of  claim 7  wherein n consists essentially of 2, 4 and 6.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.